Vitamin D analogues and their pharmaceutical use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 25, 2003
Grant Date -
N/A
app pub date -
Oct 23, 2001
filing date -
Apr 23, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to compounds of general formula (I) wherein R.sup.1 and R.sup.2, which may be the same or different, represent (C.sub.1 -C.sub.4)alkyl, and R.sup.3 represents hydrogen, halogen, (C.sub.1 -C.sub.4)alkyl, or O--(C.sub.1 -C.sub.4)alkyl, and in-vivo hydrolysable esters there with pharmaceutically acceptable acids. The present compounds are of value in the human and veterinary practice.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully